Seed structure and phosphorylation in the fuzzy coat impact tau seeding competency
Kasen, A.; Lovestam, S.; Breton, L.; Meyerdirk, L.; McPhail, J. A.; Piche, K.; Louwrier, A.; Capan, C. D.; Lee, H.; Scheres, S. H. W.; Henderson, M. X.
Show abstract
Tau is a pathogenic protein in Alzheimers (AD) and other neurodegenerative diseases. The misfolding of tau into {beta}-sheet rich elongated filaments is thought to be a key event in disease pathogenesis, followed by subsequent templated recruitment of monomeric tau into this pathogenic form. Cryo-electron microscopy has revealed that specific tau conformations characterize different diseases. In this study, we explored how tau filament core structure and post-translational modifications in its disordered fuzzy coat influence its seeding capacity in primary neurons and mice. We show that the structure of the seeds affects seeding capacity, but that the AD tau core structure alone is insufficient to capture the full seeding capacity of AD tau. Proteolytic cleavage of AD tau which removes the fuzzy coat causes a loss in seeding capacity, as does removal of phosphorylation from the fuzzy coat by phosphatase treatment. Re-phosphorylation of phosphatase-treated AD tau by kinase treatment partially restores seeding activity. Finally, we find that filaments of recombinant tau with twelve phospho-mimetic residues (PAD12 tau) with the AD fold are able to recapitulate the seeding capacity of AD tau. Combined, these results suggest that the structure of the ordered core, together with phosphorylation in the fuzzy coat, confers the seeding capacity of tau filaments.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genome-wide association study and functional validation implicates JADE1 in tauopathy 97%
- Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau 97%
- Tau phosphorylated at serine 356 is associated with Alzheimer's disease pathology and can be lowered in mouse and human brain tissue using the NUAK inhibitor WZ4003 96%
Similar papers in this journal
- The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds 97%
- The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model 97%
- Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology 97%
Similar papers in this journal
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 97%
- SETD7-mediated lysine monomethylation is abundant on non-hyperphosphorylated nuclear Tau 96%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 95%
Similar papers in this journal
- DnaJC7 specifically regulates tau seeding 97%
- Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filaments 95%
- Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.